TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Gram Medicin AB
Closing information (x1000 EUR)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
527
|
714
|
877 |
| Financial expenses |
91
|
0
|
21 |
| Earnings before taxes |
865
|
1,108
|
847 |
| EBITDA |
400
|
627
|
737 |
| Total assets |
6,748
|
4,640
|
3,640 |
| Current assets |
4,289
|
3,685
|
3,082 |
| Current liabilities |
1,786
|
271
|
255 |
| Equity capital |
4,741
|
4,149
|
3,184 |
| - share capital |
9
|
9
|
9 |
| Employees (average) |
1
|
1
|
1 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
70.3%
|
89.4%
|
87.5% |
| Turnover per employee |
527
|
714
|
877 |
| Profit as a percentage of turnover |
164.1%
|
155.2%
|
96.6% |
| Return on assets (ROA) |
14.2%
|
23.9%
|
23.8% |
| Current ratio |
240.1%
|
1359.8%
|
1208.6% |
| Return on equity (ROE) |
18.2%
|
26.7%
|
26.6% |
| Change turnover |
-162
|
-165
|
210 |
| Change turnover % |
-24%
|
-19%
|
32% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.